Physician profile
Timothy M Phillips
NPI 1992724595
$3,111.54
in general payments reported to CMS, 2019-2025
11 companies · $892 in 2025
The $892 reported for 2025 was more than what 89% of Pediatric Urology providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $51.36 · 2021: $268 · 2022: $577 · 2023: $282 · 2024: $768 · 2025: $892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,941.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,176.38 | 2019-2025 | Lithovue, Advance Xp |
| Teleflex LLC | $510.99 | 2024-2025 | Deflux, Deflux Metal Needle |
| Calyxo, INC. | $420.58 | 2024-2025 | Cvac Aspiration System |
| Karl Storz Endoscopy-America | $269.36 | 2022-2024 | Flex-X, N.A. |
| Ferring Pharmaceuticals INC. | $154.80 | 2025 | Adstiladrin |
| Ambu INC. | $140.44 | 2021 | |
| Urogen Pharma, INC. | $136.19 | 2025 | |
| Myriad Genetic Laboratories, INC. | $118.73 | 2022 | |
| Coloplast Corp | $85.16 | 2024 | |
| Palette Life Sciences, INC. | $71.11 | 2022 | |
| Profound Medical Corp. | $27.80 | 2023 | Tulsa-Pro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.